Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type | Tumor Size |
A1 | 1 | 59 | F | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 4*3.5*3.5 |
A2 | 2 | 59 | F | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 4*3.5*3.5 |
A3 | 3 | 59 | F | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 4*3.5*3.5 |
A4 | 4 | 58 | M | Bladder | Low-grade urothelial carcinoma | * | T2N0M0 | II | Malignant | * |
A5 | 5 | 58 | M | Bladder | Low-grade urothelial carcinoma | * | T2N0M0 | II | Malignant | * |
A6 | 6 | 58 | M | Bladder | Low-grade urothelial carcinoma | * | T2N0M0 | II | Malignant | * |
A7 | 7 | 72 | M | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant | * |
A8 | 8 | 72 | M | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant | * |
A9 | 9 | 72 | M | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant | * |
B1 | 10 | 70 | M | Bladder | Low-grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 4*3*2 |
B2 | 11 | 70 | M | Bladder | Low-grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 4*3*2 |
B3 | 12 | 70 | M | Bladder | Low-grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 4*3*2 |
B4 | 13 | 69 | M | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 3*3*1.5 |
B5 | 14 | 69 | M | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 3*3*1.5 |
B6 | 15 | 69 | M | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 3*3*1.5 |
B7 | 16 | 54 | M | Bladder | Low-grade urothelial carcinoma | * | T2aN0M0 | II | Malignant | 1*1*0.5 |
B8 | 17 | 54 | M | Bladder | Low-grade urothelial carcinoma | * | T2aN0M0 | II | Malignant | 1*1*0.5 |
B9 | 18 | 54 | M | Bladder | Low-grade urothelial carcinoma | * | T2aN0M0 | II | Malignant | 1*1*0.5 |
C1 | 19 | 76 | F | Bladder | High grade urothelial carcinoma | * | T1N0M0 | I | Malignant | * |
C2 | 20 | 76 | F | Bladder | High grade urothelial carcinoma | * | T1N0M0 | I | Malignant | * |
C3 | 21 | 76 | F | Bladder | High grade urothelial carcinoma | * | T1N0M0 | I | Malignant | * |
C4 | 22 | 66 | M | Bladder | High grade urothelial carcinoma | * | T2bN0M0 | II | Malignant | 5*4*3 |
C5 | 23 | 66 | M | Bladder | High grade urothelial carcinoma | * | T2bN0M0 | II | Malignant | 5*4*3 |
C6 | 24 | 66 | M | Bladder | High grade urothelial carcinoma | * | T2bN0M0 | II | Malignant | 5*4*3 |
C7 | 25 | 54 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 2*2*0.6 |
C8 | 26 | 54 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 2*2*0.6 |
C9 | 27 | 54 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 2*2*0.6 |
D1 | 28 | 46 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 2*1.5*1 |
D2 | 29 | 46 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 2*1.5*1 |
D3 | 30 | 46 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 2*1.5*1 |
D4 | 31 | 67 | F | Bladder | High grade urothelial carcinoma | * | T3N0M0 | IIIA | Malignant | 5*5*1.5 |
D5 | 32 | 67 | F | Bladder | High grade urothelial carcinoma | * | T3N0M0 | IIIA | Malignant | 5*5*1.5 |
D6 | 33 | 67 | F | Bladder | High grade urothelial carcinoma | * | T3N0M0 | IIIA | Malignant | 5*5*1.5 |
D7 | 34 | 82 | M | Bladder | High grade urothelial carcinoma | * | T1N0M0 | I | Malignant | * |
D8 | 35 | 82 | M | Bladder | High grade urothelial carcinoma | * | T1N0M0 | I | Malignant | * |
D9 | 36 | 82 | M | Bladder | High grade urothelial carcinoma | * | T1N0M0 | I | Malignant | * |
E1 | 37 | 50 | F | Bladder | High grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 7*4*3 |
E2 | 38 | 50 | F | Bladder | High grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 7*4*3 |
E3 | 39 | 50 | F | Bladder | High grade urothelial carcinoma | * | T1N0M0 | I | Malignant | 7*4*3 |
E4 | 40 | 60 | M | Bladder | High grade urothelial carcinoma | * | T2aN0M0 | II | Malignant | * |
E5 | 41 | 60 | M | Bladder | High grade urothelial carcinoma | * | T2aN0M0 | II | Malignant | * |
E6 | 42 | 60 | M | Bladder | High grade urothelial carcinoma | * | T2aN0M0 | II | Malignant | * |
E7 | 43 | 68 | M | Bladder | High grade urothelial carcinoma | * | T3bN0M0 | IIIA | Malignant | * |
E8 | 44 | 68 | M | Bladder | High grade urothelial carcinoma | * | T3bN0M0 | IIIA | Malignant | * |
E9 | 45 | 68 | M | Bladder | High grade urothelial carcinoma | * | T3bN0M0 | IIIA | Malignant | * |
F1 | 46 | 61 | M | Bladder | High grade urothelial carcinoma (sparse) | * | T3N0M0 | IIIA | Malignant | * |
F2 | 47 | 61 | M | Bladder | High grade urothelial carcinoma (sparse) | * | T3N0M0 | IIIA | Malignant | * |
F3 | 48 | 61 | M | Bladder | High grade urothelial carcinoma (sparse) | * | T3N0M0 | IIIA | Malignant | * |
F4 | 49 | 74 | F | Bladder | High grade urothelial carcinoma | * | T2bN0M0 | II | Malignant | * |
F5 | 50 | 74 | F | Bladder | High grade urothelial carcinoma | * | T2bN0M0 | II | Malignant | * |
F6 | 51 | 74 | F | Bladder | High grade urothelial carcinoma (sparse) | * | T2bN0M0 | II | Malignant | * |
F7 | 52 | 48 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 3*2*2 |
F8 | 53 | 48 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 3*2*2 |
F9 | 54 | 48 | M | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant | 3*2*2 |
G1 | 55 | 67 | M | Bladder | Chronic inflammation with hyperplasia and squamous metaplasia | * | * | * | Inflammation | * |
G2 | 56 | 67 | M | Bladder | Chronic inflammation | * | * | * | Inflammation | * |
G3 | 57 | 67 | M | Bladder | Chronic inflammation with hyperplasia and squamous metaplasia | * | * | * | Inflammation | * |
G4 | 58 | 46 | F | Bladder | Chronic inflammation | * | * | * | Inflammation | * |
G5 | 59 | 46 | F | Bladder | Chronic inflammation | * | * | * | Inflammation | * |
G6 | 60 | 46 | F | Bladder | Chronic inflammation | * | * | * | Inflammation | * |
G7 | 61 | 78 | F | Bladder | Chronic inflammation | * | * | * | Inflammation | * |
G8 | 62 | 78 | F | Bladder | Chronic inflammation | * | * | * | Inflammation | * |
G9 | 63 | 78 | F | Bladder | Chronic inflammation | * | * | * | Inflammation | * |
H1 | 64 | 51 | M | Bladder | Chronic inflammation with hyperplasia and squamous metaplasia | * | * | * | Inflammation | * |
H2 | 65 | 51 | M | Bladder | Chronic inflammation with hyperplasia and squamous metaplasia | * | * | * | Inflammation | * |
H3 | 66 | 51 | M | Bladder | Chronic inflammation | * | * | * | Inflammation | * |
H4 | 67 | 73 | M | Bladder | Chronic inflammation | * | * | * | Inflammation | * |
H5 | 68 | 73 | M | Bladder | Chronic inflammation | * | * | * | Inflammation | * |
H6 | 69 | 73 | M | Bladder | Chronic inflammation | * | * | * | Inflammation | * |
H7 | 70 | 49 | F | Bladder | Chronic inflammation with hyperplasia and squamous metaplasia | * | * | * | Inflammation | * |
H8 | 71 | 49 | F | Bladder | Chronic inflammation with hyperplasia and squamous metaplasia | * | * | * | Inflammation | * |
H9 | 72 | 49 | F | Bladder | Chronic inflammation with hyperplasia and squamous metaplasia | * | * | * | Inflammation | * |
Tissue Marker |